These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6128980)

  • 21. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
    Maekawa H
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity.
    Adelstein RS; Conti MA
    Nature; 1975 Aug; 256(5518):597-8. PubMed ID: 170529
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological intervention with platelet phospholipase A2.
    Nosal R; Jancinova V
    Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet beta-adrenoceptors.
    Kerry R; Scrutton MC
    Br J Pharmacol; 1983 Jul; 79(3):681-91. PubMed ID: 6140045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
    Nosál R; Jancinová V; Ondrias K; Jakubovský J; Balgavý P
    Biochim Biophys Acta; 1985 Dec; 821(2):217-28. PubMed ID: 2865973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of albumin upon the loss of enzymes from washed platelets.
    Rossi EC
    J Lab Clin Med; 1972 Feb; 79(2):240-6. PubMed ID: 4257926
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of platelet actomyosin activity: effect of ADP on superprecipitation and ATPase activity of human platelet actomyosin.
    Puszkin S; Puszkin E; Katz AM; Aledort LM
    Biochim Biophys Acta; 1974 Apr; 347(1):102-12. PubMed ID: 4279699
    [No Abstract]   [Full Text] [Related]  

  • 28. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphate conjugation of beta 2-adrenoceptor stimulating drugs by platelet and placental phenol sulphotransferase.
    Sodha RJ; Schneider H
    Br J Clin Pharmacol; 1984 Jan; 17(1):106-8. PubMed ID: 6140950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
    Pittner H
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
    Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The phospholipid requirement of the (Ca2+ + Mg2+)-ATPase from human platelets.
    De Metz M; Lebret M; Enouf J; Lévy-Tolédano S
    Biochim Biophys Acta; 1984 Mar; 770(2):159-65. PubMed ID: 6141806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exaprolol as a modulator of heart sarcolemmal (Na+ + K+)-ATPase. Evidence for interaction with an essential sulfhydryl group in the catalytic centre of the enzyme.
    Dzurba A; Ziegelhöffer A; Schmidtová L; Breier A; Vrbjar N; Okolicány J
    Gen Physiol Biophys; 1985 Jun; 4(3):257-64. PubMed ID: 2863195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of intracellular calcium in A-23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets.
    Nosál R; Jancinová V; Petríková M
    Biochem Pharmacol; 1994 Jun; 47(12):2207-11. PubMed ID: 7913320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of divalent cations and La3+ on contractility and ecto-ATPase activity in the guinea-pig urinary bladder.
    Ziganshin AU; Ziganshina LE; Hoyle CH; Burnstock G
    Br J Pharmacol; 1995 Feb; 114(3):632-9. PubMed ID: 7735690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Effect of beta blockers on human blood platelets in vivo.
    Zawilska K; Komarnicki M; Manka B
    Thromb Diath Haemorrh; 1975 Sep; 34(1):336. PubMed ID: 242091
    [No Abstract]   [Full Text] [Related]  

  • 37. Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?
    Michel MC; Klüppel M; Philipp T; Brodde OE
    Br J Clin Pharmacol; 1991 Jul; 32(1):105-9. PubMed ID: 1679657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Properties of anion-sensitive erythrocyte ATPase].
    Ivashchenko AT
    Vopr Med Khim; 1980; 26(5):668-71. PubMed ID: 6448513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R; Scrutton MC; Wallis RB
    Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium transport ouabain binding, and (Na+/K+)-ATPase activity in Down's syndrome platelets.
    McCoy EE; Enns L
    Pediatr Res; 1978 Jun; 12(6):685-9. PubMed ID: 149949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.